ER-independent actions of estrogen and estrogen metabolites in bone cells

Journal of Musculoskeletal Neuronal Interactions

Volumn 3, Issue 4, 2003, Pages 367-369

  Maran, Avudaiappan ^a  

^a MAYO CLINIC   (United States)

Author keywords

Activator of transcription; Estrogen metabolism; Human bone cells; Interferon; Signal transducer

Indexed keywords

2 METHOXYESTRADIOL; DRUG METABOLITE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; STEROID HORMONE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE CELL; DRUG EFFICACY; DRUG METABOLISM; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; ESTROGEN BINDING; ESTROGEN METABOLISM; ESTROGEN THERAPY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HORMONE PROTEIN COMPLEX; HUMAN; OSTEOSARCOMA; PHARMACOKINETICS; SIGNAL TRANSDUCTION;

EID: 1642513576     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gelbke HP, Knuppen R. The excretion of five different 2-hydroxyoestrogen monomethyl ethers in human pregnancy urine. J Ster Biochem 1976; 7:457-463.
2. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994; 368:237-239.
3. Mukhopadhyay T, Roth JA. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 1997; 14:379-384.
4. Schumacher G, Kataoka M, Roth JA, Mukhopadhyay T. Potent anti-tumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 1999; 5:493-499.
5. Seegers JC, Lottering ML, Grobler CJ, van Papendorp DH, Habbersett RC, Shou Y, Lehnert BE. The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells. J Steroid Biochem Mol Biol 1997; 62:253-267.
6. Pribluda VS, Gubish ER, Lavallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: an endogenous anti-angiogenic and anti-proliferative drug candidate. Cancer Metastasis Rev 2000; 19:173-179.
7. Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 1998; 58:2269-2277.
8. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 1994; 91:3964-3968.
9. Mukhopadhyay T, Roth JA. Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene 1998; 17:241-246.
10. Maran A, Zhang M, Kennedy AM, Sibonga JD, Rickard DJ, Spelsberg TC, Turner RT. 2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. Bone 2002; 30:393-398.
11. Turner RT, Evans GL. 2-methoxyestradiol inhibits longitudinal bone growth in normal female rats. Calcif Tissue Int 2000; 66:465-469.
12. Sibonga JD, Evans GL, Lotinun S, Pribluda VS, Green SJ, Turner RT. The effects of 2-methoxyestradiol on the tibial histomorphometry of the ovariectomized growing rat. 2001; (submitted).
13. Sylvia VL, Hughes T, Dean DD, Boyan BD, Schwartz Z. 17β-estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves non-genomic mechanisms. J Cell Physiol 1998; 176:435-444.
14. Sylvia VL, Walton J, Lopez D, Dean DD, Boyan BD, Schwartz Z. 17 b-estradiol-BSA conjugates and 17 b-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J Cell Biochem 2001; 81:413-429.
15. Levin ER. Cellular functions of plasma membrane estrogen receptors. Steroids 2002; 67:471-475.
16. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC. Non-genotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001; 104:719-730.
17. Kelly MJ, Lagrange AH, Wagner EJ, Ronnekleiv OK. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 1999; 64:64-75.
18. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996; 15:1292-1300.
19. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Auricchio F. Src is an initial target of sex steroid hormone action. Ann N Y Acad Sci 2002; 963:185-190.
20. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407:538-541.
21. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001; 20:6050-6059.
22. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998; 67:227-264.
23. Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 1996; 10:1578-1588.
24. Ihle JN, Kerr IM. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 1995; 11:69-74.
25. Bjornstrom L, Sjoberg M. Signal transducers and activators of transcription as downstream targets of non-genomic estrogen receptor actions. Mol Endocrinol 2002; 16:2202-2214.